[Novel strategy for GVHD treatment: possible use of mesenchymal stem cells and interleukin-21].
Katsutohsi
K
Ozaki
D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006086:Graft vs Host Disease / Q000276:immunology / Q000628:therapy*; D020544:Graft vs Leukemia Effect; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007165:Immunosuppression Therapy; D007378:Interleukins / Q000276:immunology*; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000276:immunology*; D051379:Mice; D000098546:Interleukin-21
D007074:Immunoglobulin G; D007378:Interleukins; D000098546:Interleukin-21